Well-established global building envelope specialist contractor, Crown Roofing and Cladding, is currently rolling out fingerprint drug testing across its European sites. Due to the high-risk work at heights that it carries out, Crown has a zero tolerance approach to drugs and alcohol misuse.
The company researched and purchased the innovative Intelligent Fingerprinting test to enable on-site, in-house drug testing, along with an alcohol breathalyser, with the objective of ensuring everyone is safe at work. Crown Roofing and Cladding now has plans to roll out the in-house testing approach to promote positive adherence to its drug and alcohol policies across construction sites in Ireland and other European sites.
The fingerprint drug test works by testing a simple sample of fingerprint sweat – enabling results to be determined within 10 minutes. Crown’s own well-trained staff will carry out the random tests in-house as required, acting as a deterrent to help underpin the company’s drug and alcohol policies.
Crown Roofing and Cladding was particularly attracted to the Intelligent Fingerprinting drug test because of its applicability for drug testing in the workplace. Fingerprint drug testing’s shorter ‘window of detection’ gives organisations like Crown a simple and dignified way of identifying potential employee use of cocaine, cannabis, opiates and methamphetamine in the period immediately before their working shift.
Emma O’Gorman Wall COO, Crown Roofing and Cladding says:
“As a company we are highly committed to employee and stakeholder health, safety and wellbeing. This is our constant focus. Our objective, from a health, safety and wellbeing point of view is to keep everyone safe on site and ensure every individual gets home safely each evening to their families.”
“With the help of the Intelligent Fingerprinting system, we have been able to quickly roll-out random drug and alcohol testing ourselves – all in-house. Through remote training, our Health and Safety Manager and team can conduct drug testing as and when required. We are randomly testing at one of our European sites at the moment, and are so impressed with the system that we’re now looking to roll it out to our other operational sites across Europe and Ireland.”
“The system is incredibly easy to use, and the benefit of being able to own the entire process in-house is very appealing to us. Importantly, the system tests for relevant recent drug use – rather than over a longer period – in line with workers’ union guidelines.”
